Article ID Journal Published Year Pages File Type
5824769 Clinical Therapeutics 2015 9 Pages PDF
Abstract
At the intended dose under fasting conditions, amifampridine exposure may be increased. European Union Drug Regulating Authorities Clinical Trials identifier: 2011-000596-13.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, , , , ,